# SOTYKTU
> **NDA214958** · New Drug Application · Sponsor: BRISTOL · Approved 2022-09-09
## Drug
- **FDA Application Number:** NDA214958
- **Application type:** New Drug Application
- **Brand name:** SOTYKTU
- **Generic name:** DEUCRAVACITINIB
- **Active ingredients:** DEUCRAVACITINIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BRISTOL
- **Manufacturer:** E.R. Squibb & Sons, L.L.C.
- **First approval:** 2022-09-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214958)
---
*AI Analytics · CC0 1.0*